|

Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma

RECRUITINGSponsored by Assistance Publique - Hôpitaux de Paris
Actively Recruiting
SponsorAssistance Publique - Hôpitaux de Paris
Started2020-09-02
Est. completion2030-09
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT04340986

Summary

The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.

Eligibility

Age: 18 Years+
Inclusion Criteria:

Inclusion Criteria :

* Age ≥ 18 years olds
* Medical care in Nephrology department since 2015

Cholangiocarcinoma:

\- Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease

Hepatocellular carcinoma:

* Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
* Hepatocellular histologically documented

Exclusion Criteria:

\- Lack of patient non-opposition

Conditions5

CancerCholangiocarcinomaHepatocellular CarcinomaLiver CancerLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.